690 results on '"van den Heuvel, Lambertus"'
Search Results
2. HIV-associated nephropathy in children: challenges in a resource-limited setting
3. Glomerular hyperfiltration: part 2-clinical significance in children
4. Evaluation of the efficacy of cystinosin supplementation through CTNS mRNA delivery in experimental models for cystinosis
5. Ex Vivo Test of Complement Dysregulation in Atypical Hemolytic Uremic Syndrome Kidney Transplant patients: A Pilot Study
6. The potential of RNA-based therapy for kidney diseases
7. Early Eculizumab Withdrawal in Patients With Atypical Hemolytic Uremic Syndrome in Native Kidneys Is Safe and Cost-Effective: Results of the CUREiHUS Study
8. Sickle cell nephropathy: insights into the pediatric population
9. MFSD12 depletion reduces cystine accumulation without improvement in proximal tubular function in experimental models for cystinosis
10. #2200 Kidney stem/progenitor cells can be isolated from the urine of neonates independently of their gestational age at birth
11. Biallelic Variants of MRPS36 Cause a New Form of Leigh Syndrome
12. Circulating Permeability Factors in Focal Segmental Glomerulosclerosis: In Vitro Detection
13. Proteinuria and Exposure to Eculizumab in Atypical Hemolytic Uremic Syndrome
14. Long-term follow-up including extensive complement analysis of a pediatric C3 glomerulopathy cohort
15. Mutations in Genes Encoding Subunits of the RNA Exosome as a Potential Novel Cause of Thrombotic Microangiopathy.
16. Impact of preterm birth on kidney health and development
17. Mitochondrial Disease and the Kidney With a Special Focus on CoQ10 Deficiency
18. MFSD12 depletion reduces cystine accumulation without improvement in proximal tubular function in experimental models for cystinosis.
19. Levamisole Modulation of Podocytes’ Actin Cytoskeleton in Nephrotic Syndrome
20. Functional evaluation of complement factor I variants by immunoassays and SDS-PAGE
21. Modeling complement activation on human glomerular microvascular endothelial cells
22. Long-term treated HIV infection is associated with platelet mitochondrial dysfunction
23. Nephrotic syndrome in a dish: recent developments in modeling in vitro
24. Effect of Storage Conditions on Stability of Ophthalmological Compounded Cysteamine Eye Drops
25. MFSD12depletion reduces cystine accumulation without improvement in proximal tubular function in experimental models for cystinosis
26. 93 Modeling complement activation on human glomerular microvascular endothelial cells
27. The Zebrafish Embryo as a Model Organism for Testing mRNA-Based Therapeutics
28. The complement component C5 is not responsible for the alternative pathway activity in rabbit erythrocyte hemolytic assays during eculizumab treatment
29. The role of properdin in complement-mediated renal diseases: a new player in complement-inhibiting therapy?
30. Pharmacology, Pharmacokinetics and Pharmacodynamics of Eculizumab, and Possibilities for an Individualized Approach to Eculizumab
31. Glyco-iELISA: a highly sensitive and unambiguous serological method to diagnose STEC-HUS caused by serotype O157
32. CTNS mRNA as a potential treatment for nephropathic cystinosis
33. Evaluation of the efficacy of cystinosin supplementation through CTNS mRNA delivery in experimental models for cystinosis
34. Modeling complement activation on human glomerular microvascular endothelial cells
35. Functional evaluation of complement factor I variants by immunoassays and SDS-PAGE
36. Early Eculizumab Withdrawal in Patients With Atypical Hemolytic Uremic Syndrome in Native Kidneys Is Safe and Cost-Effective:Results of the CUREiHUS Study
37. Modeling complement activation on human glomerular microvascular endothelial cells
38. Early Eculizumab Withdrawal in Patients With Atypical Hemolytic Uremic Syndrome in Native Kidneys Is Safe and Cost-Effective: Results of the CUREiHUS Study
39. Evaluation of carbohydrate-cysteamine thiazolidines as pro-drugs for the treatment of cystinosis
40. Genetic predisposition to infection in a case of atypical hemolytic uremic syndrome
41. Proteinuria and Exposure to Eculizumab in Atypical Hemolytic Uremic Syndrome
42. The Pitfall of White Blood Cell Cystine Measurement to Diagnose Juvenile Cystinosis
43. Mutational Spectrum of the CTNS Gene in Egyptian Patients with Nephropathic Cystinosis
44. Proximal tubular efflux transporters involved in renal excretion of p-cresyl sulfate and p-cresyl glucuronide: Implications for chronic kidney disease pathophysiology
45. Sensitive, reliable and easy-performed laboratory monitoring of eculizumab therapy in atypical hemolytic uremic syndrome
46. HIV-associated nephropathy in children: challenges in a resource-limited setting
47. Glomerular hyperfiltration: part 2—clinical significance in children
48. De novo SIX2 activation in human kidneys treated with neonatal kidney stem/progenitor cells
49. Challenges in diagnostic testing of nephritic factors
50. Continuously Grooved Stent Struts for Enhanced Endothelial Cell Seeding
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.